Pulmonary Aptamer Signatures in Children's Interstitial and Diffuse Lung Diseases.
Sign Up to like & getrecommendations! Published in 2019 at "American journal of respiratory and critical care medicine"
DOI: 10.1164/rccm.201903-0547oc
Abstract: RATIONALE Biomarker signatures are needed in children with interstitial and diffuse lung disease (chILD) to improve diagnostic approaches, increase our understanding of disease pathogenesis, monitor disease progression, and develop new treatment strategies. Proteomic technology using… read more here.
Keywords: pulmonary aptamer; children interstitial; interstitial diffuse; diffuse lung ... See more keywords